Lapatinib Ditosylate - ≥99.0% Purity, Total Impurity ≤1.0%, Single Impurity ≤0.3% | Pharmaceutical Intermediates For Anticancer And Antidiabetic Applications

Lapatinib Ditosylate388082-78-8
Lapatinib base231277-92-2
4-(3-fluorobenzyloxy)-3-chlorobenzenamine hydrochloride202197-26-0
N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-iodoquinazolin-4-amine231278-20-9
N-(4-(3-fluorobenzyloxy)-3-chlorophenyl)-6-bromoquinazolin-4-amine944549-41-1
5-[4-({3-chloro-4-[(3-fluorobenzyl)oxy] phenyl} amino)quinazolin-6-yl]-2-furaldehyde231278-84-5
2-(aminomethyl)-2-methylpropanamide104458-24-4

Nanjing CHICO Pharmaceutical Chemical Co., Ltd. is a private limited liability company specializing in the development of new drugs and research, development, production and trade of Lapatinib Ditosylates and pharmaceutical intermediates.

a Y99.0%, Total impurity a 1.0% ,Single impurity a 0.3%
API;Only for chemical products.

Pharmaceutical materials and intermediates

Anticancers: Lapatinib Gefitinb Dasatinb Nilotinib etc.

Antidiabetics: Sitagliptin Vildagliptin Glimepiride Nateglinide Mitiglinide etc.

Antivirals: Adefovir Tenofovir Maraviroc etc.

Cardiovasculars: Prasugrel Ivabradine Ranolazine Tolvaptan etc.

Neuromuscular blocking drugs: Rocuronium Vecuronium etc.

Antipsychoticsi Aripiprozole Duloxetine Agomelatine etc.

Other API /Intermediates: Febuxostat Racecadotril Varenicline Ramelteon etc.